Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 155c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($1.68), $1.55 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• 3M Co. (MMM) Declares $0.78 Quarterly Dividend; 1.7% Yield
• Bernstein on China Online Beauty: Very Weak July Performance